Singapore markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.2185+0.1185 (+10.77%)
At close: 03:47PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
5,880
1,221
-2,879
-28,264
Depreciation & amortisation
5,844
6,081
6,145
5,978
Deferred income taxes
-6,752
-6,262
-941
-3,237
Stock-based compensation
743
1,216
1,883
1,270
Change in working capital
4,005
-15,262
4,730
182
Accounts receivable
-1,863
-8,236
4,430
-3,505
Inventory
-4,894
-1,987
-6,660
-9
Other working capital
20,751
-1,806
-8,894
-5,714
Other non-cash items
14,752
13,606
12,223
9,819
Net cash provided by operating activities
20,970
-1,444
-1,180
5,041
Cash flows from investing activities
Investments in property, plant and equipment
-219
-362
-7,714
-10,755
Acquisitions, net
-3,416
-1,359
-482
-952
Net cash used for investing activities
-3,635
-1,721
-8,196
-11,707
Cash flows from financing activities
Debt repayment
-65,869
-24,724
-164
-369
Common stock issued
-
-
0
22,635
Dividends paid
0
0
0
0
Other financing activities
-
-
-
-297
Net cash used provided by (used for) financing activities
-18,490
6,405
663
18,683
Net change in cash
-1,155
3,240
-8,713
12,017
Cash at beginning of period
9,273
10,018
18,704
5,233
Cash at end of period
8,118
13,069
10,018
18,704
Free cash flow
Operating cash flow
20,970
-1,444
-1,180
5,041
Capital expenditure
-219
-362
-7,714
-10,755
Free cash flow
20,751
-1,806
-8,894
-5,714